Sign In
Buy FAMDF
$0.0090
-0.0004 (-4.66%)
At Close: Jun 03, 2026
Futura Medical plc (FAMDF) Q4 2025 Earnings Call Transcript
02:43pm, Monday, 04'th May 2026
Futura Medical plc (FAMDF) Q4 2025 Earnings Call Transcript
Microsoft Q3 results top expectations, driven by Intelligent Cloud strength
12:25pm, Wednesday, 29'th Apr 2026
Microsoft Corp (NASDAQ:MSFT) reported fiscal third quarter earnings that exceeded Wall Street expectations, driven by continued strength in its cloud and...
Futura Medical refines strategy and evolves commercial model after tough 2025
03:41am, Wednesday, 29'th Apr 2026
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX), the consumer healthcare company behind erectile dysfunction gel Eroxon, said it has refined its strategy...
Futura Medical refines strategy and evolves commercial model after tough 2025
02:46am, Wednesday, 29'th Apr 2026
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX), the consumer healthcare company behind erectile dysfunction gel Eroxon, said it has refined its strategy and is evolving its commercial model followi
Gold just had one of its worst weeks in 40 years. Is it time to buy the dip?
09:06am, Tuesday, 24'th Mar 2026
The metal dropped 17% in five trading days, briefly erasing all of its 2026 gains. The sell-off looks dramatic. The case for holding is stronger than it...
Futura Medical reports positive trial results for upgraded erectile dysfunction gel
03:42am, Monday, 23'rd Mar 2026
The consumer healthcare company's new Intense formula showed stronger early effects than its existing product in a 223-person study Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX), the consumer heal
Futura Medical reports positive trial results for upgraded erectile dysfunction gel
03:17am, Monday, 23'rd Mar 2026
The consumer healthcare company's new Intense formula showed stronger early effects than its existing product in a 223-person study Futura Medical PLC...
Nike North America sales growth and inventory reset support turnaround: analysts
10:18am, Thursday, 05'th Feb 2026
Nike Inc (NYSE:NKE, XETRA:NKE)’s brand momentum appears to be improving, according Jefferies analysts, who reiterated a ‘Buy’ rating on the stock and a $110...
Nasdaq set to lead decline as Alphabet spending plans spook investors
07:40am, Thursday, 05'th Feb 2026
US stocks have been called sharply lower on Thursday after jobs cuts in the past month were higher than expected, while Google parent Alphabet is set to...
Nasdaq drags major indexes lower as Alphabet spending plans spook investors
05:44am, Thursday, 05'th Feb 2026
10:40am: Stocks show resilience beneath tech selloff The decline in US equities is driven largely by weakness in major technology stocks, but underlying...
Qualcomm: A tough start to 2026 in prospect after Q4 earnings beat
04:29am, Thursday, 05'th Feb 2026
This was not a classic earnings disappointment. Qualcomm Inc (NASDAQ:QCOM, XETRA:QCI) exceeded consensus forecasts on both revenue and adjusted earnings per...
Futura secures US patent protection for Eroxon and women's sexual health product
02:30am, Thursday, 05'th Feb 2026
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) has secured a US notice of allowance for a continuation patent covering its erectile dysfunction treatment Eroxon and an in-development women's sexual
Futura secures US patent protection for Eroxon and women’s sexual health product
02:28am, Thursday, 05'th Feb 2026
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) has secured a US notice of allowance for a continuation patent covering its erectile dysfunction treatment...
Super Micro Computer shares jump on Q2 results, upbeat outlook
05:50am, Wednesday, 04'th Feb 2026
Super Micro Computer Inc (NASDAQ:SMCI) shares surged more than 13% after the company reported fiscal second quarter earnings that exceeded analyst...
Futura Medical shares climb on upbeat revenue forecast and cash position
04:46am, Wednesday, 04'th Feb 2026
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) shares rose as much as 10% in early trading after the company said it expects to report revenue of £1.7 million for 2025, ahead of earlier guidance.
